Motor rehabilitation for Parkinson’s disease • 2025 MDS Congress
Rehabilitation for movement disorders, like PD, has become increasingly prevalent for patient care. Prof. Alice Nieuwboer discusses how technology has shaped the field, how neurologists can support patient exercise, and what future updates she looks forward to.
-------- Â
--------
Current genetic landscape for movement disorders • 2025 MDS Congress
The field of genetics often moves quickly, making it a challenge to stay informed. Dr. Gerard Seranza breaks down the current landscape, new discoveries and technologies, and what changes we can expect in the upcoming years.
-------- Â
--------
Disease modification and Parkinson’s disease: Clinical trial design and population selection • 2025 MDS Congress
There have been nearly 30 years of disease modifying trials for PD, but little success. Prof. Tanya Simuni breaks down clinical trial design for a heterogenous disease like PD and discusses the future goals and importance of a biological definition.
-------- Â
--------
Achievements and future goals: An interview with MDS President • 2025 MDS Congress
Dr. Victor Fung reflects on his term as MDS President and his appreciation for the accomplishments that were achieved. He further discusses his future hopes and goals of the Society and the #mdscongress.
-------- Â
--------
Updates in tauopathies • 2025 MDS Congress
Dr. Yaroslau Compta discusses how the view of co-pathologies has changed the view of many disorders, including tauopathies. He dives into the current state of clinical trials for PSP and what those results may mean for the future of biomarkers.
Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors.